Literature DB >> 26617717

Expression of cystatin C and its effect on EC9706 cells in esophageal carcinoma.

Yan Yan1, Kun Zhou2, Liping Wang1, Yue Zhou3, Xinfeng Chen4, Qingxia Fan1.   

Abstract

OBJECTIVE: To investigate the expression of cystatin C gene and its effect on the proliferation, apoptosis and invasiveness of EC9706 cells in esophageal carcinoma.
METHODS: 56 cases of esophageal carcinoma were randomly collected from our hospital. Samples of human esophageal carcinomas and matched normal esophageal mucosal epithelium were selected by resection operation from these patients. Expression of cathepsin B and cystatin C in these specimens were determined by immunohistochemistry and qRT-PCR. Next, lentiviral vectors of over-expression and interference for cystatin C gene were constructed, and both were transfected into EC9706 cells, and then the levels of cystatin C mRNA and protein were detected by qRT-PCR and Western blot. The effect of over and low-expressed cystatin C on the proliferation, apoptosis and invasiveness of esophageal carcinoma cells were detected by MTT assay, flow cytometry and Transwell assay.
RESULTS: Compared with normal esophageal epithelial tissues, mRNA and protein levels of cathepsin B and cystatin C in esophageal carcinoma tissues were significantly increased (P<0.05). Lentiviral vectors of over-expression and interference for cystatin C gene were successfully transfected into EC9706 cells. Over or low-expression cystatin C had no effect on EC9706 cells proliferation but had a reverse relationship with the apoptosis. However, cystatin C over-expression significantly decreased tumor invasiveness (P<0.05) while the invasiveness of EC9706 cells was significantly enhanced by RNAi-mediated abrogation of cystatin C gene expression (P<0.05).
CONCLUSION: Over-expressed cystatin C could inhibit the invasiveness of esophageal carcinoma cells.

Entities:  

Keywords:  Cathepsin B; apoptosis; cystatin C; esophageal carcinoma; invasiveness; proliferation

Mesh:

Substances:

Year:  2015        PMID: 26617717      PMCID: PMC4637532     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  25 in total

1.  Inhibition of B16 melanoma metastasis by overexpression of the cysteine proteinase inhibitor cystatin C.

Authors:  J L Cox; P S Sexton; T J Green; N A Darmani
Journal:  Melanoma Res       Date:  1999-08       Impact factor: 3.599

2.  Constitutive expression of cytotoxic proteases and down-regulation of protease inhibitors in LGL leukemia.

Authors:  Ravi Kothapalli; Ratna D Bailey; Irina Kusmartseva; Shrikant Mane; P K Epling-Burnette; Thomas P Loughran
Journal:  Int J Oncol       Date:  2003-01       Impact factor: 5.650

3.  Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells.

Authors:  Santhi D Konduri; Niranjan Yanamandra; Khawar Siddique; Arun Joseph; Dzung H Dinh; William C Olivero; Meena Gujrati; Gregory Kouraklis; Amand Swaroop; Athanassios P Kyritsis; Jasti S Rao
Journal:  Oncogene       Date:  2002-12-12       Impact factor: 9.867

4.  Growth stimulation of 3T3 fibroblasts by cystatin.

Authors:  Q Sun
Journal:  Exp Cell Res       Date:  1989-01       Impact factor: 3.905

5.  Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C.

Authors:  S Coulibaly; H Schwihla; M Abrahamson; A Albini; C Cerni; J L Clark; K M Ng; N Katunuma; O Schlappack; J Glössl; L Mach
Journal:  Int J Cancer       Date:  1999-11-12       Impact factor: 7.396

6.  Expression analysis of cystatin C and M in laser-capture microdissectioned human breast cancer cells--a preliminary study.

Authors:  Nadarajah Vigneswaran; Jean Wu; Susan Muller; Wolfgang Zacharias; Sena Narendran; Lavinia Middleton
Journal:  Pathol Res Pract       Date:  2005       Impact factor: 3.250

7.  Detection of cathepsin B, cathepsin L, cystatin C, urokinase plasminogen activator and urokinase plasminogen activator receptor in the sera of lung cancer patients.

Authors:  Qingyong Chen; Jun Fei; Lijun Wu; Zhongyong Jiang; Yuquan Wu; Yun Zheng; Guohua Lu
Journal:  Oncol Lett       Date:  2011-05-11       Impact factor: 2.967

8.  Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation.

Authors:  M Heinrich; J Neumeyer; M Jakob; C Hallas; V Tchikov; S Winoto-Morbach; M Wickel; W Schneider-Brachert; A Trauzold; A Hethke; S Schütze
Journal:  Cell Death Differ       Date:  2004-05       Impact factor: 15.828

9.  [Preliminary study on the expression of cystatin C in primary liver cancer].

Authors:  He He; Rui-Xue Lü; Jin Xu; Li-Bo Liang; Ming-Feng Zhang; Zhen-Mei An; Heng-Jian Huang
Journal:  Sichuan Da Xue Xue Bao Yi Xue Ban       Date:  2013-11

10.  Cathepsin B, cathepsin H, cathepsin X and cystatin C in sera of patients with early-stage and inflammatory breast cancer.

Authors:  J Decock; N Obermajer; S Vozelj; W Hendrickx; R Paridaens; J Kos
Journal:  Int J Biol Markers       Date:  2008 Jul-Sep       Impact factor: 3.248

View more
  2 in total

1.  Externally added cystatin C reduces growth of A375 melanoma cells by increasing cell cycle time.

Authors:  Hanna Wallin; Samar Hunaiti; Magnus Abrahamson
Journal:  FEBS Open Bio       Date:  2021-05-02       Impact factor: 2.693

2.  LncRNA Snhg1, a non-degradable sponge for miR-338, promotes expression of proto-oncogene CST3 in primary esophageal cancer cells.

Authors:  Yan Yan; Qingxia Fan; Liping Wang; Yue Zhou; Jianhua Li; Kun Zhou
Journal:  Oncotarget       Date:  2017-05-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.